You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (40) |
Back to Search
Preclinical safety assessment of substrates for human p-glycoprotein: bioinformatics-assisted selection of
- In: Posters J - Translational Research and Individualized Medicines
- At: PSWC, Melbourne (Australia) (2014)
- Type: Poster
- Poster code: PJ-004
- By: PAULETTI, Giovanni M. (University of Cincinnati, James L. Winkle College of Pharmacy, Cincinnati, United States of America)
- Co-author(s): Pal, Ramavati (University of Cincinnati, Cincinnati, United States of America)
Menon, Anil (University of Cincinnati, Cincinnati, United States of America) - Abstract:
Background: Regulatory standards mandate preclinical safety assessment of new molecular entities in two [quotright]relevant[quotrightB]animal species prior to first-in-human studies. To assist in rational selection of [quotright]relevant[quotrightB]animal species, P-glycoprotein (P-gp) primary sequences for human and common preclinical animal..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026